the therapeutic safety indices ( cardiovascular effect dose/neuroleptic dose ) for haloperidol regarding alpha-adrenergic blockade , hypotension , myocardial depression and ventricular conduction delay were 4 , 145 , 235 and 125 , respectively , whereas these indices for chlorpromazine and for thioridazine were 0.06 , 2 , 4 , 6 and 0.05 , 1 , 3 and 1 , respectively .
C0040615
neuroleptic
C0018546
haloperidol